Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RDNT | US
-0.18
-0.33%
Healthcare
Diagnostics & Research
30/06/2024
08/06/2026
54.16
54.40
55.27
53.53
RadNet Inc. together with its subsidiaries provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging computed tomography positron emission tomography nuclear medicine mammography ultrasound diagnostic radiology fluoroscopy and other related procedures as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute display store and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast lung and prostate images as well as AI solutions for prostate cancer screening. RadNet Inc. was founded in 1981 and is headquartered in Los Angeles California.
View LessStrong Revenue Growth (> 10%)
High Short-term Volatility
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
44.2%1 month
42.1%3 months
35.9%6 months
43.8%378.67
-
5.72
1.95
0.53
18.87
3.51
2.32
242.18M
4.01B
4.01B
-
7.73
2.40K
13.90
4.58
4.63
5.18
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
4.24
Range1M
11.91
Range3M
14.66
Rel. volume
0.69
Price X volume
30.13M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corporation | TWST | Diagnostics & Research | 70.04 | 4.10B | 1.18% | n/a | 17.75% |
| Senseonics Holdings Inc | SENS | Diagnostics & Research | 7.13 | 3.82B | 6.90% | n/a | 154.97% |
| Doximity Inc. | DOCS | Health Information Services | 20.3 | 3.77B | -1.41% | 54.38 | 1.54% |
| Celcuity Inc | CELC | Diagnostics & Research | 87.43 | 3.24B | -0.96% | n/a | 54.62% |
| Privia Health Group Inc. Common Stock | PRVA | Health Information Services | 21.41 | 2.56B | -1.02% | 148.58 | 1.14% |
| Biodesix Inc | BDSX | Diagnostics & Research | 14.95 | 2.17B | -3.30% | n/a | 169.94% |
| Neogen Corporation | NEOG | Diagnostics & Research | 9.07 | 1.97B | 1.91% | n/a | 28.45% |
| Omnicell Inc | OMCL | Health Information Services | 41.95 | 1.93B | -2.44% | n/a | 51.17% |
| NeoGenomics Inc | NEO | Diagnostics & Research | 10.95 | 1.40B | 0.46% | n/a | 66.22% |
| WGS | WGS | Health Information Services | 51.8 | 1.40B | -0.79% | n/a | 60.84% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Thor Industries Inc | THO | Recreational Vehicles | 77.37 | 4.10B | 2.21% | 23.44 | 27.88% |
| Cinemark Holdings Inc | CNK | Media - Diversified | 31.45 | 3.85B | 0.70% | 27.93 | 934.91% |
| Polaris Industries Inc | PII | Recreational Vehicles | 67.68 | 3.77B | 2.45% | 14.48 | 170.51% |
| Harley-Davidson Inc | HOG | Recreational Vehicles | 24.91 | 3.28B | 1.71% | 7.33 | 218.58% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 16.94 | 3.04B | 0.47% | n/a | -571.93% |
| VeriFone Systems Inc | PAY | Building Products & Equipment | 20.53 | 2.56B | -1.77% | 102.46 | 2.10% |
| LCI Industries | LCII | Recreational Vehicles | 92.6 | 2.36B | -1.76% | 25.82 | 77.66% |
| IMAX Corporation | IMAX | Media - Diversified | 39.12 | 2.06B | 0.38% | 54.26 | 110.44% |
| HNI Corporation | HNI | Building Products & Equipment | 31.37 | 1.48B | 0.74% | 22.12 | 76.47% |
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 46.45 | 1.46B | -3.21% | 51.60 | 88.92% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 18.87 | 12.67 | Expensive |
| Ent. to Revenue | 3.51 | 44.00 | Cheaper |
| PE Ratio | 378.67 | 40.09 | Expensive |
| Price to Book | 5.72 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 35.94 | 59.59 | Lower Risk |
| Debt to Equity | 1.95 | -14.36 | Expensive |
| Debt to Assets | 0.53 | 0.34 | Expensive |
| Market Cap | 4.01B | 13.71B | Emerging |